(Q38000901)

26 August 2017

title

Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision (English)

1 reference

26 August 2017

R N Lown

1

1 reference

26 August 2017

B E Shaw

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

9 April 2012

1 reference

Bone Marrow Transplantation

26 August 2017

published in

1 reference

26 August 2017

volume

48

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

210-219

1 reference

Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Haematopoietic stem cell transplantation for autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Reduced-intensity stem cell transplantation for hematological malignancies: current status and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Hematopoietic stem cell transplantation: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Understanding donors' motivations: a study of unrelated bone marrow donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Attrition of potential bone marrow donors at two key decision points leading to donation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The HLA polymorphism and susceptibility to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

21 January 2018

The IMGT/HLA database

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Asthma on Tristan da Cunha: looking for the genetic link. The University of Toronto Genetics of Asthma Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Cystic fibrosis in the Ohio Amish: gene frequency and founder effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Founder effects and genetic variability in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Gene and haplotype frequencies for the loci hLA-A, hLA-B, and hLA-DR based on over 13,000 german blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Advances in HLA: practical implications for selecting adult donors and cord blood units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Overview of registries, HLA typing and diversity, and search algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Factors associated with attrition from a national bone marrow registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The association of donor center characteristics with attrition from the national marrow donor registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Safety of bone marrow stem cell donation: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Transmission of Human Immunodeficiency Virus Type 1 from a Seronegative Organ and Tissue Donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Allogeneic bone marrow transplantation-related transmission of human T lymphotropic virus type I (HTLV-I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

HTLV-I-associated myelopathy following allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Hepatitis B virus transmission in organ, tissue, and cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The monitoring of hematopoietic stem cell transplant donors and recipients from endemic areas for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Renal transplant-associated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Malaria in a liver transplant recipient: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Malaria with leukopenia in a renal transplant patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Mixed Plasmodium falciparum and Plasmodium vivax malaria in orthotopic liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

A model for Chagas disease involving transmission by vectors and blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Transfusion-associated transmission of West Nile virus, United States 2003 through 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Prevention of West Nile virus transmission by blood transfusion: a comparison of nucleic acid test screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Transmission of West Nile virus from an organ donor to four transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Donor derived malignancy following transplantation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Fulminant Crohn's colitis after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Recipients of blood or blood products "at vCJD risk".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The impact of variant CJD on transfusion practices in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Creutzfeldt-Jakob disease (CJD) after blood product transfusion from a donor with CJD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The EBMT activity survey 2009: trends over the past 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Bone marrow biopsy morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Obesity in anaesthesia and intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Weight and thirty-year mortality of men in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

A multidimensional assessment of obese patients with obstructive sleep apnoea syndrome (OSAS): a study of psychological, neuropsychological and clinical relationships in a disabling multifaceted disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Obesity and endocrine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Endocrine and metabolic disease. Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Anaesthesia in the morbidly obese. A comparison of anaesthetic and analgesic regimens for upper abdominal surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Pulmonary physiologic changes of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Oxygen transport and venous admixture in the extremely obese. Influence of anaesthesia and artificial ventilation with and without positive end-expiratory pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Preoperative prediction of postoperative deep vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Effect of obesity on the pharmacokinetics of drugs in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Criteria for initiation and evaluation of minority donor programs and application to the example of donors of Turkish descent in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Regional differences in HLA antigen and haplotype frequency distributions in Germany and their relevance to the optimization of hematopoietic stem cell donor recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

National cord blood bank to recruit ethnic donors aggressively

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

High-resolution HLA alleles and haplotypes in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Monitoring the international use of unrelated donors for transplantation: the WMDA annual reports.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Definitions of histocompatibility typing terms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

The distribution of HLA alleles revealed a founder effect in the geographically isolated Chinese population, Drung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated Donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

What is the impact of HLA mismatches detected by high-resolution techniques on the outcome of unrelated donor bone marrow transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

On willingness to be a bone marrow donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Registered bone marrow donors' views on bodily donations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Natural selection and the evolutionary history of major histocompatibility complex loci

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Assessment of barriers to bone marrow donation by unrelated African-American potential donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Implications of HLA sequence-based typing in transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Relevance of KIR gene polymorphisms in bone marrow transplantation outcome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Fatal acute HIV infection with aplastic anaemia, transmitted by liver graft

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Transmission of the hepatitis-C virus by tissue transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

The risk of transfusion transmission of Chagas disease in Mexico City

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Transfusion-associated transmission of babesiosis in New York State

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Pulmonary sarcoidosis following stem cell transplantation: is it more than a chance occurrence?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Autoimmune diseases and autoimmunity post-bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Scotblood 2007: Tackling local and global issues in transfusion medicine - donor recruitment, effective use of blood, stem cell plasticity, and vCJD

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Bovine spongiform encephalopathy, variant CJD, and blood transfusion: beefer madness?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Overweight, obesity, and pancreatic cancer: beyond risk alone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Overweight and cancer

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Abdominal obesity and the risk of recurrent deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.54

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.54

1 reference

Dimensions Publication ID

26 August 2017

1022759906

0 references

1 reference